Enrolling By InvitationNCT05210803
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
PHASE2 · 116 planned enrolment
- Countries listed
- 1
- Registry update
- August 5, 2026
immortal.lifeTrial registrations containing the exact intervention label Standard of care.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 116 planned enrolment
PHASE2 · 26 planned enrolment
Phase not reported · 200 planned enrolment
Phase not reported · 11 planned enrolment
Phase not reported · 324 planned enrolment
Phase not reported · 50 planned enrolment